ArticlePharmaceuticals (Basel, Switzerland)2025
Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan.
Fu-Shun Yen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.